American Financial Tribune: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Financial Tribune.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on March 8, 2026

Mar. 8, 2026

GovCore Opens Oklahoma City Office to Strengthen Local Client Support

EIN Presswire

Mar. 8, 2026

Artivist Jacqueline Rudolph to Exhibit Powerful Portraits and Sculptural Works at ArtExpo New York 2026

EIN Presswire

Mar. 8, 2026

Instacoins Concierge Launches 'Finesse' Initiative on International Women’s Day

EIN Presswire

Mar. 8, 2026

Global Finance Enters 'End of Predictability' as Demand for Roger Spitz’s Uncertainty Keynotes Surges

EIN Presswire

Mar. 8, 2026

CLASS ACTION INVESTOR ALERTS: Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ultragenyx and Mereo BioPharma and Encourages Investors to Contact the Firm

GlobeNewswire

Mar. 8, 2026

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BlackRock TCP and Plug Power and Encourages Investors to Contact the Firm

GlobeNewswire

Mar. 8, 2026

CoreWeave (CRWV) Securities Fraud Class Action Lawsuit Filed; March 13, 2026, Lead Plaintiff Deadline

GlobeNewswire

Mar. 8, 2026

Dyne Therapeutics Announces Initiation of Phase 3 HARMONIA Trial of Z-Basivarsen in Myotonic Dystrophy Type 1 (DM1)

GlobeNewswire

Mar. 8, 2026

Dyne Therapeutics Announces New Positive Cardiopulmonary Results from DELIVER Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD)

GlobeNewswire

Mar. 8, 2026

Dianthus Therapeutics to Host Conference Call and Webcast to Discuss the Interim Responder Analysis Results of the Phase 3 Captivate Trial of Claseprubart in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

GlobeNewswire

Mar. 8, 2026

Emergenetics Leadership and Team Development Programs Help Organizations Strengthen and Improve Team Performance, Communication and Collaboration

GlobeNewswire

Mar. 8, 2026

ROSEN, LEADING INVESTOR RIGHTS COUNSEL, Encourages Hub Group, Inc. Investors to Inquire About Securities Class Action Investigation – HUBG

GlobeNewswire

Mar. 8, 2026

Xenon to Announce Topline Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures on Monday, March 9, 2026

GlobeNewswire

Mar. 8, 2026

Bronstein, Gewirtz & Grossman LLC Urges Lakeland Industries, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

GlobeNewswire

Mar. 8, 2026

Bronstein, Gewirtz & Grossman LLC Urges Plug Power Inc. Investors to Act: Class Action Filed Alleging Investor Harm

GlobeNewswire

Mar. 8, 2026

Bronstein, Gewirtz & Grossman LLC Urges Ultragenyx Pharmaceutical Inc. Investors to Act: Class Action Filed Alleging Investor Harm

GlobeNewswire

Mar. 8, 2026

Halemont Capital Identifies Preparation Gap Among Founders Approaching Investors

EIN Presswire

Mar. 8, 2026

ROSEN, LEADING INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX

GlobeNewswire

Mar. 8, 2026

Dream Chasers Releases Shareholder Governance Update for Carver Bancorp, Inc. (OTC: CARV)

EIN Presswire

Mar. 8, 2026

NEXTGEN Brand Strategy: Why the Future Belongs to Firms Who Control AI—Not Those Controlled by It

EIN Presswire